Indaptus Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
133.2M
on 2026-06-30, from 305K on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-28 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
$100.0M
Agreement of 2026-09-04. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Warrants
175K
Warrants of every class as tagged in the XBRL facts on 2025-09-30, exercise price $0.01. 10-Q ↗
Cash
3.1 quarters
$11.6M on 2026-06-30 ÷ $3.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-09-08 | Private placement | 20,338,974 | not read | $24.0M | 8-K ↗ |
| 2026-06-17 | Private placement | 20,000,000 | $0.60 | $12.0M | 8-K ↗ |
| 2025-12-22 | Private placement | not read | $6.00 | $6.0M | 8-K ↗ |
| 2025-06-12 | Private placement | not read | not read | $2.3M | 8-K ↗ |
| 2025-01-12 | Private placement | 2,109,383 | not read | $2.2M | 8-K ↗ |
Also on file: $2.3M convertible notes, 2025-06-12 8-K ↗ · a 1-for-28 reverse split, 2025-06-26 8-K ↗ · a 1-for-2 reverse split, 2026-02-26 8-K ↗